Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Immunodeficiency Diseases01:25

Immunodeficiency Diseases

1.2K
Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
1.2K
Types of Intermediate Filaments01:31

Types of Intermediate Filaments

3.9K
The intermediate filaments are an essential component of the cytoskeleton. Presently six types of intermediate filament have been identified. Type I and II are acidic and basic keratin proteins. Type III is of mesodermal origin and comprises four proteins: vimentin, desmin, glial fibrillary acidic protein (GFAP), and peripherin. Vimentin is commonly found in mesenchymal cells, desmin in muscle cells, GFAP in astrocytes, while peripherin is found in peripheral nervous system neurons (PNS). Type...
3.9K
Diabetes Mellitus: Overview and Type I Subtype01:22

Diabetes Mellitus: Overview and Type I Subtype

3.4K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
3.4K
Diabetes: Symptoms, Diagnosis, and Complications01:15

Diabetes: Symptoms, Diagnosis, and Complications

898
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
898
Autoimmune Disorders01:29

Autoimmune Disorders

723
Autoimmune diseases are a group of disorders in which the body's immune system mistakenly attacks its own cells, tissues, and organs. This results from an overactive immune response against substances and tissues normally present in the body. Let's delve into the concept and mechanism of autoimmune diseases from an immune system point of view, explore different causes and examples of such diseases, and discuss potential solutions.
Concept and Mechanism of Autoimmune Diseases
The immune...
723

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Model-free classification of X-ray scattering signals applied to image segmentation.

Journal of applied crystallography·2018
Same author

Measurement of the Soft-Drop Jet Mass in pp Collisions at sqrt[s]=13  TeV with the ATLAS Detector.

Physical review letters·2018
Same author

Measurement of jet fragmentation in Pb+Pb and

The European physical journal. C, Particles and fields·2018
Same author

Precision measurement and interpretation of inclusive

The European physical journal. C, Particles and fields·2018
Same author

Search for new phenomena using the invariant mass distribution of same-flavour opposite-sign dilepton pairs in events with missing transverse momentum in

The European physical journal. C, Particles and fields·2018
Same author

Search for Low-Mass Dijet Resonances Using Trigger-Level Jets with the ATLAS Detector in pp Collisions at sqrt[s]=13  TeV.

Physical review letters·2018

Related Experiment Video

Updated: Oct 3, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K

[When to consider type I interferonopathy in adulthood?]

C David1, M-L Frémond2

  • 1Université de Paris, Institut Imagine, laboratoire de neurogénétique et neuroinflammation, 24, boulevard du Montparnasse, 75015 Paris, France.

La Revue De Medecine Interne
|February 18, 2022
PubMed
Summary
This summary is machine-generated.

Type I interferonopathies (IP1) are rare genetic disorders caused by overactive type I interferon (IFN) pathways. Targeted therapies inhibiting type I IFN show promise in managing these severe conditions.

Keywords:
GeneticsGénétiqueImmunityImmunitéInterferonInterferonopathyInterféronInterféronopathie

More Related Videos

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.1K
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

12.1K

Related Experiment Videos

Last Updated: Oct 3, 2025

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
10:00

High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes

Published on: March 24, 2015

13.5K
Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α
08:26

Development and Validation of an Ultrasensitive Single Molecule Array Digital Enzyme-linked Immunosorbent Assay for Human Interferon-α

Published on: June 14, 2018

12.1K
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
11:44

A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3

Published on: January 24, 2016

12.1K

Area of Science:

  • Immunology
  • Genetics
  • Rare Diseases

Background:

  • Type I interferonopathies (IP1) are a group of Mendelian diseases.
  • Characterized by overactivation of the type I interferon (IFN) pathway.
  • Caused by monogenic or digenic mutations in innate immunity proteins.

Purpose of the Study:

  • To describe the heterogeneous nature of IP1.
  • To outline the broad clinical spectrum and genetic basis.
  • To highlight the potential of targeted therapies.

Main Methods:

  • Review of existing literature and patient data.
  • Analysis of genetic mutations affecting the type I IFN pathway.
  • Evaluation of clinical manifestations and treatment responses.

Main Results:

  • IP1 presents with diverse symptoms including neurological, dermatological, joint, pulmonary, and hematological issues.
  • A common feature is the overexpression of type I IFN, indicated by an 'interferon signature'.
  • JAK inhibitors targeting type I IFN have shown beneficial effects on patient symptoms.

Conclusions:

  • IP1 encompasses a wide range of clinical presentations and genetic causes.
  • The 'interferon signature' is a key diagnostic marker.
  • Targeted therapies offer a promising avenue for improved patient management and outcomes.